JP2021522793A5 - - Google Patents
Info
- Publication number
- JP2021522793A5 JP2021522793A5 JP2020561726A JP2020561726A JP2021522793A5 JP 2021522793 A5 JP2021522793 A5 JP 2021522793A5 JP 2020561726 A JP2020561726 A JP 2020561726A JP 2020561726 A JP2020561726 A JP 2020561726A JP 2021522793 A5 JP2021522793 A5 JP 2021522793A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- sequence
- acid sequence
- item
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862666547P | 2018-05-03 | 2018-05-03 | |
| US62/666,547 | 2018-05-03 | ||
| US201862779998P | 2018-12-14 | 2018-12-14 | |
| US62/779,998 | 2018-12-14 | ||
| PCT/US2019/030469 WO2019213442A1 (en) | 2018-05-03 | 2019-05-02 | MULTISPECIFIC BINDERS OF TGFβ-SUPERFAMILY LIGANDS AND USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021522793A JP2021522793A (ja) | 2021-09-02 |
| JP2021522793A5 true JP2021522793A5 (cg-RX-API-DMAC7.html) | 2022-05-13 |
Family
ID=68386158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561726A Pending JP2021522793A (ja) | 2018-05-03 | 2019-05-02 | ＴＧＦβスーパーファミリーリガンドの多特異性バインダーおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12103959B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3788066A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021522793A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019262139A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3099527A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019213442A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021119136A1 (en) * | 2019-12-10 | 2021-06-17 | Acceleron Pharma Inc. | Single-arm actriia and actriib heteromultimers and methods for treating pulmonary hypertension |
| CA3196443A1 (en) * | 2020-11-04 | 2022-05-12 | Hq Han | Novel bifunctional multispecific antagonists capable of inhibiting multiple ligands of tgf-beta family and uses thereof |
| US20240277807A1 (en) * | 2021-06-11 | 2024-08-22 | Acceleron Pharma Inc. | Actrii proteins and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3253628A1 (en) | 2010-03-05 | 2025-11-29 | The Johns Hopkins University | Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| BR112016014952A2 (pt) | 2014-02-10 | 2017-09-19 | Merck Patent Gmbh | Inibição direcionada de tgfbeta |
| JP6631865B2 (ja) * | 2014-08-11 | 2020-01-15 | 日本化薬株式会社 | ＴＧＦβ阻害機能を持つキメラタンパク質 |
| US10358476B2 (en) | 2015-04-06 | 2019-07-23 | Acceleron Pharma Inc. | Single arm type I and type II receptor fusion proteins and uses thereof |
| MA41920B1 (fr) * | 2015-04-06 | 2021-05-31 | Acceleron Pharma Inc | Protéines de fusion de récepteur type i et type ii à bras unique et leurs utilisations |
| CA3029890A1 (en) | 2016-07-07 | 2018-01-11 | Acceleron Pharma Inc. | Tgf-beta superfamily heteromultimers and uses thereof |
| AU2017338915B2 (en) * | 2016-10-05 | 2024-11-21 | Acceleron Pharma Inc. | TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof |
| CN110036025B (zh) | 2016-10-05 | 2024-03-22 | 阿塞勒隆制药公司 | 变体ActRIIB蛋白及其用途 |
| CN206301918U (zh) * | 2016-12-23 | 2017-07-04 | 深圳国人通信股份有限公司 | 一种介质移相器 |
| US12168683B2 (en) | 2018-05-03 | 2024-12-17 | Acceleron Pharma Inc. | Binders of TGFβ-superfamily ligands and uses thereof |
| CA3103427A1 (en) | 2018-06-15 | 2019-12-19 | Acceleron Pharma Inc. | Bi-and tri-functional fusion proteins and uses thereof |
-
2019
- 2019-05-02 US US17/052,785 patent/US12103959B2/en active Active
- 2019-05-02 JP JP2020561726A patent/JP2021522793A/ja active Pending
- 2019-05-02 CA CA3099527A patent/CA3099527A1/en active Pending
- 2019-05-02 EP EP19796599.9A patent/EP3788066A4/en active Pending
- 2019-05-02 WO PCT/US2019/030469 patent/WO2019213442A1/en not_active Ceased
- 2019-05-02 AU AU2019262139A patent/AU2019262139A1/en not_active Abandoned
-
2024
- 2024-08-21 US US18/811,531 patent/US20250109179A1/en active Pending